Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : People crawled time : 01:00 save search
Artax Biopharma Expands Company's Scientific Advisory Board
Published: 2022-11-15 (Crawled : 01:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.25%
H: 0.01%
C: -1.96%
biopharma
Immune Therapeutics, Inc. Announces Management Change; Moves Forward with Repositioning Strategy and Long-acting TLR4 (Toll Like Receptor 4) Antagonist JKB-122 Development
Published: 2022-11-09 (Crawled : 01:00) - biospace.com/
IMUN | $0.093 214.52% 1.8K
|
Manufacturing
|
| O: -9.45%
H: 0.86%
C: 0.86%
jkb-122 management
Fate Therapeutics Appoints Brian T. Powl as Chief Commercial Officer
Published: 2022-06-30 (Crawled : 01:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: -1.7%
H: 0.0%
C: 0.0%
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -2.13%
H: 2.75%
C: 1.77%
commercial therapeutics
Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer
Published: 2022-05-24 (Crawled : 01:00) - biospace.com/
KODK | $4.62 0.22% 0.65% 540K
|
Electronic Technology
|
| O: -2.76%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
CWBR | $0.9003 -11.88% 360
|
Health Technology
|
| O: 0.17%
H: 5.38%
C: -0.17%
Cyteir Therapeutics Announces the Appointment of Stephen Sands to Board of Directors
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
CYT | $3.02 2.65% 1M
|
Manufacturing
|
| O: -3.44%
H: 0.0%
C: 0.0%
ces therapeutics
CytoDyn Announces Leadership Transition Plan to Support Regulatory Approval and Commercialization of Leronlimab
Published: 2022-01-25 (Crawled : 01:00) - biospace.com/
CYDY | $0.1509 0.06% 810K
|
Manufacturing
|
| O: -0.42%
H: 2.2%
C: -7.14%
commercialization approval
Merus Appoints Shannon Campbell as Chief Commercial Officer and Regains Worldwide Rights to MCLA-145
Published: 2022-01-25 (Crawled : 01:00) - biospace.com/
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
|
| O: -1.81%
H: 2.56%
C: 1.11%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.73%
H: 0.33%
C: -0.86%
mcla-145 commercialization
Kymera Therapeutics Appoints Karen Weisbach as Vice President, People and Culture and Jolly Bhatia as Vice President, Quality
Published: 2021-07-29 (Crawled : 01:00) - biospace.com/
XFOR | $1.255 4.58% 4.38% 3M
|
Health Technology
|
| O: 0.0%
H: 5.18%
C: 3.97%
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: 0.25%
H: 0.99%
C: -3.88%
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
|
| O: 0.85%
H: 1.64%
C: -2.14%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.01%
H: 1.3%
C: -0.14%
Outset Medical Announces Departure of CFO and Appointment of Nabeel Ahmed as Interim CFO
Published: 2021-07-01 (Crawled : 01:00) - biospace.com/
EGHT | $2.185 1.63% 1.6% 960K
|
Technology Services
|
| O: -0.18%
H: 1.08%
C: -0.61%
OM | News | $2.33 3.56% 3.43% 830K
|
Health Technology
|
| O: 0.02%
H: 1.27%
C: -2.08%
EBAY | News | $50.38 0.86% 0.85% 4.3M
|
Consumer Services
|
| O: 0.0%
H: 0.79%
C: -0.58%
Inogen Announces Appointment of Chief Medical Officer
Published: 2021-06-08 (Crawled : 01:00) - biospace.com/
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 0.15%
H: 0.74%
C: -0.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: -0.99%
INGN | $6.75 -4.8% -5.04% 260K
|
Health Technology
|
| O: 0.59%
H: 2.42%
C: 0.19%
Sangamo Therapeutics Appoints Prathyusha Duraibabu, CPA, MBA, to Chief Financial Officer
Published: 2021-05-24 (Crawled : 01:00) - biospace.com/
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: 1.02%
H: 0.05%
C: -2.29%
Outset Medical Appoints MedTech Executive Katie Szyman to Board of Directors
Published: 2021-05-24 (Crawled : 01:00) - biospace.com/
OM | News | $2.33 3.56% 3.43% 830K
|
Health Technology
|
| O: 0.17%
H: 2.76%
C: -0.22%
NARI S | $38.58 -0.16% -0.16% 790K
|
Health Technology
|
| O: 1.1%
H: 2.49%
C: 0.5%
Ra Medical Systems Appoints Susanne L. Meline to its Board of Directors
Published: 2021-02-04 (Crawled : 01:00) - biospace.com/
RMED | $0.594 0.0% 78K
|
Health Technology
|
| O: 2.1%
H: 21.47%
C: 17.79%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.